Navigation Links
Malvern initiates European user group meetings for chemical imaging

WORCESTERSHIRE , England, 21 June 2007, Malvern Instruments has held the inaugural meeting in Europe for users of the company's near infrared chemical imaging (NIR-CI) systems. The one-day event, which took place on 13 June 2007 was hosted by AstraZeneca in Macclesfield, UK. Malvern customers from some of the world's major pharmaceutical companies joined Malvern's technical and scientific teams for a program that included oral and poster presentations on the application of NIR-CI, and the opportunity to exchange experiences and ideas.

During the first sessions, presentations from users included: 'Chemical imaging and quality by design'; 'Moving NIR chemical imaging from lab to process-based methodology'; 'Applications of NIR imaging in drug development'; and 'Content uniformity determination'. The final parts of the day were devoted to instrumentation and software, together with a session on morphological imaging.

Linda Kidder, Malvern's product manager for chemical imaging systems, felt that the day was extremely valuable. "This was our first chemical imaging user meeting in Europe and we were very pleased with the response from our customers," she said. "Attendees came from a number of different European countries and shared their experiences through oral or poster presentations. The pharmaceutical industry is currently the biggest user of Malvern's chemical imaging systems and it was good to hear more about the various applications for which they are being used." A similar meeting will be held for chemical imaging users in the United States later in the year.

Malvern's recently launched SyNIRgi system underlines the continuing migration of NIR-CI technology from its specialist roots into routine use as a highly desirable, quantitative analytical tool. The hallmarks of SyNIRgi are its rugged construction with no moving parts, modular software that enables the development of turnkey soluti ons, and expandability options for automation accessories. Since NIR chemical imaging provides robust, reliable and automated data collection that is coupled tightly with quantitative, statistical, objective, reproducible and automated data processing tools, it is highly suited for routine analytical measurements. SyNIRgi is designed with this in mind. <>


High resolution image attached or available from Trish Appleton,

Kapler Communications Ref: MAL/JOB/1229

About Malvern Instruments

Malvern Instruments is a global company that develops, manufactures and markets advanced analytical systems used in characterizing a wide variety of materials, from bulk powders to the latest nanomaterials and delicate macromolecules. Innovative technologies and powerful software produce systems that deliver industrially relevant data enabling customers to make the connection between micro (eg particle size) and macro (bulk) material properties (rheology) and chemical composition (chemical imaging). Malvern laboratory, on-line and in-line solutions are proven in sectors from cement to pharmaceuticals and support the understanding, improvement and optimization of many industrial processes.

Headquartered in Malvern, UK, the company has subsidiary organizations in all major European markets, North America, China, Korea and Japan, key partnerships in India, a global distributor network and a number of applications laboratories around the world. <>

For press information, please contact

Trish Appleton, Kapler Communications

Suite 2, Cressner House, 1 2 Huntingdon Street, St Neots, Cambs PE19 1BD UK

Tel: +44 (0) 1480 471117; Fax: +44 (0) 1480 471118

USA contact:

Marisa Fraser, Malvern Instruments Inc

10 Southville Road, Southborough, MA 01772, USA

Tel: +1 508 480 0200; Fax: +1 508 460 9692

Please send sales enquiries to:

Alison Vines, Malvern Instruments Ltd

Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ UK

Tel: +44 (0) 1684 892456; Fax: +44 (0) 1684 892789


Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
7. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
8. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
9. Inspire Announces Presentations at Two European Scientific Conferences
10. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
11. Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent at European Association for Palliative Care Congress
Post Your Comments:
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Volumes: Global Analysis (United States, China, Japan, Brazil, United ... to their offering. ... healthcare business planners, provides surgical procedure volume data in ... with an in-depth analysis of growth drivers and inhibitors, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):